All News
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue?
Dr. Kevin Winthrop reviews all things COVID-related including abstract L01 from the 2020 ACR Convergence, steroids and DMARDs, vaccination status - and how long this pandemic will last.
Read Article
Rheumatoid arthritis and lung disease in the spotlight at #ACR20
Rheumatoid arthritis (RA) has long been established to have pulmonary manifestations such as interstitial lung disease (ILD), and several research groups are pursuing this respiratory burden of RA at #ACR20.
Read Article
Our latest article is asking: "Erosions on X-ray: can we delegate this to the computers?" by David Liew ( @drdavidliew) #ACR20
https://t.co/YvKjAWebT9 https://t.co/mUCv8ycep2
Links:
Dr. John Cush RheumNow ( View Tweet)
Increase Active Learning in Rheumatology Training: Dr. Robert Chao ( @doctorRBC) interviews Dr. Stefanie Wade about #ACR20 session.
https://t.co/7U0GLfZpGy https://t.co/uvZ1oJGZNa
Links:
Dr. John Cush RheumNow ( View Tweet)
Have you listened to our latest podcast? We are sharing highlights from #ACR20 and view on the best/newest studies.
https://t.co/v9knKnr8R2 https://t.co/wquQQC7rBl
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @uptoTate : March 2020 telemed implementation in WI & CA, no-show rates decreased & total visit volume remained ^. Particularly true for rural offices, while urban center didn't see reduced no-show rates. ? healthcare delivery disparities #ACR20
Dr. John Cush RheumNow ( View Tweet)
Watch our video on the "Safety of JAKs: Venou Thromboemboic Risk" by Dr. Kevin Winthrop #ACR20
https://t.co/toY1MHo88H https://t.co/FNhrrgkit8
Links:
Dr. John Cush RheumNow ( View Tweet)
"The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis" by Dr. Richard Conway ( @RichardPAConway)
https://t.co/VG1ah3Nq5c https://t.co/jORhfQn3EC
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @Janetbirdope : IA steroids for knee OA are superior to lidocaine! Clever RCT of 27 knee OA w either 40mg methylpred acetate + lidocaine vs lidocaine w social cues to exercise. Knee injury & OA outcome score superior for IA steroids in prelim data
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
"RT @KDAO2011 : Meta-analysis of studies - 4104 pregnancies axSpa/PsA: higher risk for: preterm labor, small for gestational age, C-section
No change in miscarriage/stillbirth, gest.diabetes
#ACR20, @rheumnow Abstr#1771
https://t.co/xl1YyRPavX"
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? #ACR20
https://t.co/UHKxNcpojh https://t.co/0rvOmEVrK7
Links:
Dr. John Cush RheumNow ( View Tweet)
A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011) #ACR20 https://t.co/95Y3ilCwyq https://t.co/Oje9vcbHnt
Links:
Dr. John Cush RheumNow ( View Tweet)
Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur Kavanaugh #ACR20
https://t.co/kJxdgoL5EI https://t.co/uYUwUr53lL
Links:
Dr. John Cush RheumNow ( View Tweet)
Watch our video titled "Outcomes for Rheumatic Disease Patients with COVID-19" with Dr Kathryn Dao ( @KDAO2011) #ACR20
https://t.co/771RLB0pqA https://t.co/glr98MQHac
Links:
Dr. John Cush RheumNow ( View Tweet)
Reactive Arthritis - Chronic v. Acute: Dr. Janet Pope (@Janetbirdope) #ACR20 https://t.co/BNFqgrckLq https://t.co/oEPe8hfG37
Links:
Dr. John Cush RheumNow ( View Tweet)
Healthcare Disparities: Dr. Eric Dein ( @ejdein1) discusses abstracts #0049 and #0045 presented at #ACR20.
https://t.co/hUbVnGO4Ji https://t.co/jHMnKHY3UH
Links:
Dr. John Cush RheumNow ( View Tweet)
Telemedicine Studies: A Trainee’s Perspective by Mrinalini Dey ( @DrMiniDey ) COVID-19 has shifted face to face to consultations--an important change in rheumatology practice. #ACR20 https://t.co/IzvyeFC8w8 https://t.co/SIQxfuUuEk
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our article titled Undifferentiated Autoinflammatory Syndrome Called VEXAS by @RheumNow. We recap Saturday's session on autoinflammatory syndromes featuring Dr. Dan Kastner. #ACR20 https://t.co/4jELWl5f88 https://t.co/l95F9C0V31
Links:
Dr. John Cush RheumNow ( View Tweet)
Moderna mRNA-1273 vaccine, developed for COVID-19, yielded 94.5% efficacy in early results of the phase 3 COVE trial. 90 who were COVID-19 pos were in a placebo group and that 5 patients were in the mRNA-1273 vaccine group. https://t.co/9245wj3kph
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Mrinalini Dey ( @DrMiniDey) Interviews Dr. Marwan Bukhari. He talks about the significant increase in submissions to Rheumatology - especially COVID-19 related, the machine learning and other studies. #ACR20
https://t.co/kVE6Fy718f https://t.co/8XDhBl8knS
Links:
Dr. John Cush RheumNow ( View Tweet)
